News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Aerovate Therapeutics, Inc.
Aerovate Therapeutics to Explore Strategic Alternatives
July 08, 2024
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces 24-Week Topline Results from the Phase 2b Portion of IMPAHCT Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
June 17, 2024
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Presents Baseline Data from the Phase 2b Portion of the IMPAHCT Trial at the American Thoracic Society 2024 International Conference
May 21, 2024
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
May 13, 2024
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
March 27, 2024
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces Full-Year 2023 Financial Results and Business Highlights
March 25, 2024
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Board of Directors Appoints Habib Dable as Board Chair
March 06, 2024
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces Simultaneous Completion of Enrollment in Phase 2b Portion and Enrollment of First Patient into Phase 3 in the IMPAHCT Trial Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension
November 20, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces Third Quarter Financial Results and Business Highlights
November 13, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces Second Quarter Financial Results and Business Highlights
August 14, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Appoints Habib Dable To Its Board of Directors
July 11, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics to Present at Jefferies Global Healthcare Conference
June 01, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Presents Nonclinical Pharmacokinetic Data in Support of AV-101, a Novel Dry Powder Inhaled Formulation of Imatinib, at the American Thoracic Society (ATS) 2023 International Conference
May 22, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
May 15, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces Full-Year 2022 Financial Results and Business Highlights
March 29, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics to Present at Cowen 43rd Annual Health Care Conference
March 02, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Appoints Donald Santel To Its Board of Directors
January 23, 2023
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Publishes Results of Phase 1 Study Evaluating AV-101 for the Treatment of Pulmonary Arterial Hypertension in ERJ Open Research
November 17, 2022
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Announces Third Quarter 2022 Financial Results
November 14, 2022
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Aerovate Therapeutics Presents Novel Phase 2b/Phase 3 IMPAHCT Trial Design at CHEST Annual Meeting 2022
October 18, 2022
From
Aerovate Therapeutics, Inc.
Via
GlobeNewswire
Tickers
AVTE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.